Development of semisolid pharmaceutical forms with mometasone furoate

1 Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and aging. Immunology. 2020;160(2):116-25. Search in Google Scholar

2 Iqbal B, Ali J, Baboota S. Recent advances and development in epidermal and dermal drug deposition enhancement technology. Int J Dermatol. 2018;57(6):646-60. Search in Google Scholar

3 Neubert RHH. Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm. 2011;77(1):1-2. Search in Google Scholar

4 Mahalingam R, Li X, Jasti BR. Semisolid dosages: ointments, creams, and gels. Pharm Manuf Handb. 2008;1:267-312. Search in Google Scholar

5 Chang C, Zhang L. Cellulose-based hydrogels: Present status and application prospects. Carbohyd Polym. 2011;84(1):40-53. Search in Google Scholar

6 Vlaia L, Coneac G, Olariu I, Vlaia V, Lupuleasa D. Cellulose-derivatives-based hydrogels as vehicles for dermal and transdermal drug delivery. Emerging concepts in analysis and applications of hydrogels. 2016;2:64. Search in Google Scholar

7 Shelgavkar DD, Dhole VM, Singh V, Pande S. Development and evaluation of oxiconazole nitrate hydrogel as a topical drug delivery system. Innov Pharma Pharmacother. 2017;5(2):76-83. Search in Google Scholar

8 Dhurke R, Ramyasree D. Pulsatile Delivery System for Antihypertensive Drug. Cur Asp Pharm Res Dev. 2022;9:100-10. Search in Google Scholar

9 Faergemann J, Christensen O, Sjövall P, Johnsson A, Hersle K, Nordin P, et al. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. JEADV. 2000;14(5):393-6. Search in Google Scholar

10 Spada F, Barnes TM, Greive KA. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. Australasian J of Dermat. 2018;59(3):e168-e74. Search in Google Scholar

11 Mijaljica D, Spada F, Harrison IP. Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations. J Fun. 2022;8(8):812. Search in Google Scholar

12 Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch dermatol. 1985;121(1):63-7. Search in Google Scholar

13 Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clinic, Cosm Invest Dermatol. 2020;13:1041. Search in Google Scholar

14 Tatu AL, Ionescu MA, Nwabudike LC. Contact allergy to topical mometasone furoate confirmed by rechallenge and patch test. Am J Ther. 2018;25(4):e497-e8. Search in Google Scholar

15 Monica L-L, Jordi G, Francisco F-C. In situ bioadhesive film-forming system for topical delivery of mometasone furoate: Characterization and biopharmaceutical properties. J Drug Deliv Sci Tech. 2020;59:101852. Search in Google Scholar

16 Mehta AB, Nadkarni NJ, Patil SP, Godse KV, Gautam M, Agarwal S. Topical corticosteroids in dermatology. Ind j dermatol, vener leprol. 2016;82:371. Search in Google Scholar

17 Kurian A, Barankin B. Delivery vehicle advances in dermatology. Fam Pract Ed. 2011;7:4-5. Search in Google Scholar

18 Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm res. 1992;9(1):45-51. Search in Google Scholar

19 Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm. 2008;68(3):453-66. Search in Google Scholar

20 Shinde G, Desai P, Shelke S, Patel R, Bangale G, Kulkarni D. Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, in vitro and in vivo performance. J Dermatol Treat. 2022;33(2):885-96. Search in Google Scholar

21 Ference JD, Last AR. Choosing topical corticosteroids. Amer fam phys. 2009;79(2):135-40. Search in Google Scholar

22 Tadicherla S, Ross K, Shenefelt PD, Fenske NA. Topical corticosteroids in dermatology. JDD. 2009;8(12):1093-105. Search in Google Scholar

23 Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls Publishing, Treasure Island 2018. Search in Google Scholar

24 Raposo SSC. Pharmaceutical topical dosage forms as carriers for glucocorticoids: Universidade de Lisboa (Portugal); 2013. Search in Google Scholar

25 Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS j. 2010;12(3):263-71. Search in Google Scholar

26 Vigata M, Meinert C, Hutmacher DW, Bock N. Hydrogels as drug delivery systems: A review of current characterization and evaluation techniques. Pharm. 2020;12(12):1188. Search in Google Scholar

27 Caccavo D. An overview on the mathematical modeling of hydrogels’ behavior for drug delivery systems. Int J Pharm. 2019;560:175-90. Search in Google Scholar

28 Parashar B, Kabra A, Chandel A. Formulation and evaluation of gel containing miconazole nitrate an antifungal agent. Int J Pharm Res Rev. 2013;2(6):18-28. Search in Google Scholar

29 Panraksa P, Udomsom S, Rachtanapun P, Chittasupho C, Ruksiriwanich W, Jantrawut P. Hydroxypropyl Methylcellulose E15: A Hydrophilic Polymer for Fabrication of Orodispersible Film Using Syringe Extrusion 3D Printer. Polymers-Basel. 2020;12(11):2666. Search in Google Scholar

30 Chen H-H. Rheological properties of HPMC enhanced Surimi analyzed by small-and large-strain tests: I. The effect of concentration and temperature on HPMC flow properties. Food hydrocolloids. 2007;21(7):1201-8. Search in Google Scholar

31 Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev. 2012;64:163-74. Search in Google Scholar